Market Research Reports, Inc. has announced the addition of “Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2014” research report to their offering. See more at- http://mrr.cm/Zds

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: March 31, 2014
 Number of Pages: 366
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 2,000
Price For Site License: USD 4,000
Price For Global User License: USD 6,000
Delivery Time: Within 24 Hours (During Working Days)

3. www.MarketResearchReports.com
About the Report
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Infections Pipeline Review, H1 2014 provides an overview
of the Methicillin-Resistant Staphylococcus Aureus
(MRSA) Infections’s therapeutic pipeline.
This report provides comprehensive information on the
therapeutic development for Methicillin-Resistant
Staphylococcus Aureus (MRSA) Infections, complete with
comparative analysis at various stages, therapeutics
assessment by drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type, along
with latest updates, and featured news and press
releases.

4. www.MarketResearchReports.com
Scope:
The report provides a snapshot of the global therapeutic
landscape of Methicillin-Resistant Staphylococcus Aureus
(MRSA) Infections
The report reviews key pipeline products under drug profile
section which includes, product description, MoA and R&D brief,
licensing and collaboration details & other developmental
activities
The report reviews key players involved in the therapeutics
development for Methicillin-Resistant Staphylococcus Aureus
(MRSA) Infections and enlists all their major and minor projects
The report summarizes all the dormant and discontinued
pipeline projects

5. www.MarketResearchReports.com
Scope Continues:
A review of the Methicillin-Resistant Staphylococcus Aureus
(MRSA) Infections products under development by companies
and universities/research institutes based on information
derived from company and industry-specific sources
Pipeline products coverage based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
A detailed assessment of monotherapy and combination
therapy pipeline projects
Coverage of the Methicillin-Resistant Staphylococcus Aureus
(MRSA) Infections pipeline on the basis of target, MoA, route of
administration and molecule type
Latest news and deals relating related to pipeline products

6. www.MarketResearchReports.com
Reason to Buy:
Provides strategically significant competitor information, analysis, and
insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and
create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading
companies
Identify and understand important and diverse types of therapeutics
under development for Methicillin-Resistant Staphylococcus Aureus
(MRSA) Infections
Plan mergers and acquisitions effectively by identifying key players of
the most promising pipeline
Devise corrective measures for pipeline projects by understanding
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections pipeline
depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline

7. www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Late Stage Products
3. Drug Profiles
4. Appendix
5. Methodology
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

8. www.MarketResearchReports.com
Company Coverage(Partial List)
1. Eli Lilly and Company
2. Genentech, Inc.
3. AmpliPhi Biosciences Corporation
4. Takeda Pharmaceutical Company Limited
5. Piramal Enterprises Limited
6. Melinta Therapeutics, Inc
7. Aphios Corporation
8. Cubist Pharmaceuticals, Inc.
9. The Medicines Company
10. Wockhardt Limited
11. Paratek Pharmaceuticals, Inc.
12. Alchemia Limited
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

9. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center

10. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/Zds
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)